Magnus Ekström
171 – 180 of 210
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
(
- Contribution to journal › Article
-
Mark
Risk of cancer after lung transplantation for COPD
(
- Contribution to journal › Article
-
Mark
In response to C Walshe, ‘The state of play’
(
- Contribution to journal › Letter
-
Mark
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-Arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness : Breathlessness, Exertion and Morphine Sulfate (BEAMS) study protocol
(
- Contribution to journal › Article
-
Mark
Palliative oxygen for chronic breathlessness : What new evidence?
(
- Contribution to journal › Scientific review
-
Mark
Risk factors for developing hypoxic respiratory failure in COPD
(
- Contribution to journal › Article
-
Mark
A nationwide structure for valid Long-Term oxygen therapy : 29-Year prospective data in Sweden
(
- Contribution to journal › Article
-
Mark
Chronic breathlessness associated with poorer physical and mental health-related quality of life (SF-12) across all adult age groups
(
- Contribution to journal › Article
-
Mark
Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status
(
- Contribution to journal › Article
-
Mark
Incident opioid drug use and adverse respiratory outcomes among older adults with COPD
(
- Contribution to journal › Letter